The board of directors of Town Health International Medical Group Limited announced that Mr. Liu Gefeng has been appointed as an executive Director and a deputy chairman of the Company with effect from 22 December 2022. Mr. Liu, aged 56, obtained his bachelor 's degree in economics and master 's degree in economics from the Renmin University of Chinain July 1989 and January 1999, respectively. Mr. Liu worked at (in English, for identification purpose only, China Youngster's Books Publishing Corporation) from October 1989 to June 1992.

During the period from June 1992 to May 2000, Mr. Liu worked at various financial institutions in the People's Republic of China ("PRC"), including China CITIC Bank, Hainan Machinery Trust Investment Company Shenyin & Wanguo , Securities Company Limited and Zhong Bao Trust Investments Company Mr. Liu worked at China Life Insurance (Group) Company from May 2000 to September 2003 and China Life Insurance Company Limited from September 2003 to Septem ber 2022, with his last position at the latter being deputy general manager of the investment management center. Mr. Liu has been appointed as a member of the management committee of China Life Private Equity Investment Company Limited ("China Life Private Equity") since September 2022. As at the date of this announcement, China Life Private Equity is a wholly-owned subsidiary of China Life Insurance, a substantial shareholder (having the meaning ascribed to it in the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited ("Listing Rules")) of the Company.

Mr. Liu was appointed as an assistant to the director of the Development and Reform Commission of Guangxi Zhuang Autonomous Region from October 2013 to November 2015. Mr. Liu was appointed as the deputy director of the management committee of the Tianjin Port Free Trade Zone from November 2015 to December 2017. The Board further announces that Dr. Tsang Wah Tak, Kenneth ("Dr. Tsang"), an executive Director, has been appointed as a Deputy Chairman with effect from 22 December 2022.

The biographical details of Dr. Tsang are set out below: Dr. Tsang, aged 61, was appointed as an executive Director on 11 November 2022 and a member of each of the Remuneration Committee and the nomination committee of the Board on 12 December 2022. Dr. Tsang obtained the bachelor's degree in Medicine and Surgery in July 1986 and the degree of Doctor of Medicine in December 1995 from the University of Glasgow. Dr. Tsang has become a registered medical practitioner by the Medical Council of Hong Kong since 1996.

Dr. Tsang was elected to the Membership of the Royal Colleges of Physicians of the United Kingdom in November 1989, as a Fellow by Hong Kong College of Physicians in January 1996, as a Fellow by the Hong Kong Academy of Medicine in the specialty of Medicine in October 1996, as a Collegiate Member of the Royal College of Physicians and Surgeons of Glasgow in July 2000, as a Physician Fellow of the Royal College of Physicians and Surgeons of Glasgow in March 2001, to the Fellowship of Royal College of Physicians of London in May 2001, as a Fellow of the American College of Chest Physicians in October 1997 and the American College of Clinical Pharmacology in February 1998. Dr. Tsang has been accredited in Respiratory Medicine from August 1993 and in Internal Medicine from July 1994 by the Hong Kong College of Physicians. Dr. Tsang is also currently a director of a number of subsidiaries of the Company.

Dr. Tsang was an Associate Editor in Respirology. Dr. Tsang was appointed as Adjunct Professor in the Faculty of Health and Social Sciences at The Hong Kong Polytechnic University from November 2005 to October 2007, and was appointed as a Section Head in the Respiratory Disorders Faculty of Faculty of 1000 Medicine. Dr. Tsang was appointed as the Chairman of the Hong Kong Lung Foundation from 2007 to 2009 and has been an Executive Board Member of the Hong Kong Lung Foundation since 2009.

Dr. Tsang was appointed as the President of the Hong Kong Thoracic Society from 2001 to 2003, and is currently a Council Member of the Hong Kong Thoracic Society. Dr. Tsang has been appointed as the Vice-President of The Society of Physicians of Hong Kong since 2008. Dr. Tsang has been a member of the Grant Review Board of the Health and Medical Research Fund Research Council since October 2003.

Dr. Tsang was a Distinguished Professor at Guangzhou Medical University (formerly known as Guangzhou Medical College) in the PRC from November 2011 to November 2014. Dr. Tsang has been appointed as Honorary Clinical Professor in the Department of Medicine at The University of Hong Kong since 2013. Dr. Tsang has been registered as Specialist in Respiratory Medicine since March 1998.

Dr. Tsang was a director of (i) Pegasus Investments Limited, a private company incorporated in Hong Kong and dissolved by deregistration on 22 April 2022 under the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) ("Chapter 622"); (ii) Pixel Investments Limited, a private company incorporated in Hong Kong and dissolved by deregistration on 14 April 2022 under Chapter 622; (iii) Sharp Wealthy Limited, a private company incorporated in Hong Kong and dissolved by deregistration on 3 November 2017 under Chapter 622; (iv) Hong Kong Medical Specialists Limited, a private company incorporated in Hong Kong and dissolved by deregistration on 23 September 2016 under Chapter 622; and (v) University Medical Specialists Limited, a private company incorporated in Hong Kong and dissolved by deregistration on 22 July 2011 under the then prevailing Companies Ordinance (Chapter 32 of the Laws of Hong Kong). Dr. Tsang has confirmed that Pegasus Investments Limited, Pixel Investments Limited, Sharp Wealthy Limited, Hong Kong Medical Specialists Limited and University Medical Specialists Limited were inactive and solvent prior to their dissolution, and there was no wrongful act on his part leading to the dissolution of such companies, and that he is not aware of any actual or potential claim that has been or will be made against him as a result of their dissolution.